All 1 tracked stories fall under one category: fda-approval. Connected Care is most often covered alongside AI-powered innovations, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Connected Care
All 1 tracked stories fall under one category: fda-approval. Connected Care is most often covered alongside AI-powered innovations, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.7. We currently track 1 Biotech story that mention Connected Care, all published on August 1, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Connected Care. Shared-story counts are live from our verified record — not editorial picks.
Philips' Q2 earnings highlighted a 4% comparable sales increase, driven by regulatory approvals for its AI-driven imaging technologies and the launch of SmartIQ, positioning the company as a key enabler of precision diagnostics in biopharma.